Related Experiment Videos
Hibernating myocardium in patients with coronary artery disease: identification and clinical importance
R Ferrari1, G La Canna, R Giubbini
1Cattedra di Cardiologia, Università di Brescia, Italy.
Insights
Dobutamine echocardiography and nuclear imaging help identify hibernating myocardium, distinguishing viable from infarcted heart tissue. This distinction is crucial for predicting recovery after revascularization and improving patient survival.
Area of Science:
- Cardiology
- Medical Imaging
- Nuclear Medicine
Background:
- Hibernating myocardium, characterized by depressed contractile function in viable myocytes post-ischemia, requires differentiation from infarcted tissue.
- Successful revascularization of hibernating myocardium improves mechanical function and correlates with long-term survival.
- Distinguishing hibernating from infarcted myocardium is clinically vital as only hibernating tissue recovers function post-reperfusion.
Purpose of the Study:
- To evaluate the utility of low-dose dobutamine echocardiography for identifying hibernating myocardium.
- To compare the effectiveness of dobutamine echocardiography with nuclear imaging techniques (Thallium-201 and 99mTc-Sestamibi) for assessing myocardial viability.
- To determine the sensitivity and specificity of dobutamine echocardiography in identifying viable myocardium.
Main Methods:
- Low-dose dobutamine administration with echocardiographic monitoring of contractile function.
- Intraoperative epicardial echocardiography to assess recovery of akinetic areas post-coronary artery bypass surgery.
- Rest-redistribution imaging with Thallium-201 and 99mTc-Sestamibi imaging for myocardial viability assessment.
Main Results:
- Dobutamine echocardiography demonstrated 93% sensitivity and 78% specificity for identifying viable myocardium.
- Thallium-201 imaging showed high sensitivity (93%) but low specificity (44%).
- 99mTc-Sestamibi imaging provided information on perfusion and function, differentiating stunning from hibernation based on coronary flow.
Conclusions:
- Low-dose dobutamine echocardiography is a useful tool for identifying hibernating myocardium and quantifying intraoperative risk.
- Nuclear imaging techniques, particularly 99mTc-Sestamibi, offer valuable insights into myocardial viability, perfusion, and function.
- Limitations include beta-receptor downregulation affecting dobutamine response and the inability to differentiate hibernating from stunned myocardium with echocardiography alone.
Abstract:
The term hibernating myocardium describes a particular outcome of myocardial ischemia in which myocytes show a chronically depressed contractile ability but remain viable. Revascularization of hibernating tissue causes a recovery of mechanical function that correlates with long-term survival. Therefore it is important clinically to distinguish hibernating from infarcted myocardium, since asynergies due to hibernation will improve on reperfusion, whilst those due to infarct will not. One suggested technique to identify hibernating myocardium is to stimulate the myocytes acutely, but briefly, by administration of inotropic agents while monitoring contractile function by echocardiography. We report our experience on the use of low dosages of dobutamine. Myocardial viability was validated by measuring the recovery in contraction of the akinetic areas after coronary artery bypass surgery by means of intraoperative epicardial echocardiography. The test has a sensitivity of 93% and a specificity of 78%. It is useful for identification of viable myocardium and also for quantification of intraoperative risk in individual patients. Limitations of this test are related to the presence of downregulation of beta receptors and to the impossibility of differentiating hibernating from stunned myocardium. Another useful technique of identifying hibernating myocardium is the use of radionuclear markers for viability. In our experience the two most important tests are (1) rest-redistribution imaging of thallium 201 (which has a high sensitivity of 93% but a low specificity of 44%) and (2) 99mTc-Sestamibi imaging, which provides information on both perfusion and function with a single injection. This latter technique allows differentiation between stunning and hibernating on the basis of coronary flow which is preserved in stunning and reduced in hibernation.